95 related articles for article (PubMed ID: 10701154)
1. Intestinal pathogen or IBD, same T-cell response.
Michetti P
Inflamm Bowel Dis; 2000 Feb; 6(1):63-4. PubMed ID: 10701154
[No Abstract] [Full Text] [Related]
2. Role of bacterial intimin in colonic hyperplasia and inflammation.
Higgins LM; Frankel G; Connerton I; Gonçalves NS; Dougan G; MacDonald TT
Science; 1999 Jul; 285(5427):588-91. PubMed ID: 10417389
[TBL] [Abstract][Full Text] [Related]
3. Citrobacter rodentium infection in mice elicits a mucosal Th1 cytokine response and lesions similar to those in murine inflammatory bowel disease.
Higgins LM; Frankel G; Douce G; Dougan G; MacDonald TT
Infect Immun; 1999 Jun; 67(6):3031-9. PubMed ID: 10338516
[TBL] [Abstract][Full Text] [Related]
4. Dietary vitamin D3 deficiency alters intestinal mucosal defense and increases susceptibility to Citrobacter rodentium-induced colitis.
Ryz NR; Lochner A; Bhullar K; Ma C; Huang T; Bhinder G; Bosman E; Wu X; Innis SM; Jacobson K; Vallance BA
Am J Physiol Gastrointest Liver Physiol; 2015 Nov; 309(9):G730-42. PubMed ID: 26336925
[TBL] [Abstract][Full Text] [Related]
5. Helicobacter-induced inflammatory bowel disease in IL-10- and T cell-deficient mice.
Burich A; Hershberg R; Waggie K; Zeng W; Brabb T; Westrich G; Viney JL; Maggio-Price L
Am J Physiol Gastrointest Liver Physiol; 2001 Sep; 281(3):G764-78. PubMed ID: 11518689
[TBL] [Abstract][Full Text] [Related]
6. The eae gene of Citrobacter freundii biotype 4280 is necessary for colonization in transmissible murine colonic hyperplasia.
Schauer DB; Falkow S
Infect Immun; 1993 Nov; 61(11):4654-61. PubMed ID: 8406863
[TBL] [Abstract][Full Text] [Related]
7. Activation of RegIIIbeta/gamma and interferon gamma expression in the intestinal tract of SCID mice: an innate response to bacterial colonisation of the gut.
Keilbaugh SA; Shin ME; Banchereau RF; McVay LD; Boyko N; Artis D; Cebra JJ; Wu GD
Gut; 2005 May; 54(5):623-9. PubMed ID: 15831905
[TBL] [Abstract][Full Text] [Related]
8. Host defences to Citrobacter rodentium.
MacDonald TT; Frankel G; Dougan G; Goncalves NS; Simmons C
Int J Med Microbiol; 2003 Apr; 293(1):87-93. PubMed ID: 12755369
[TBL] [Abstract][Full Text] [Related]
9. Direct detection of eae-positive bacteria in human and veterinary colorectal specimens by PCR.
Hubbard AL; Harrison DJ; Moyes C; McOrist S
J Clin Microbiol; 1998 Aug; 36(8):2326-30. PubMed ID: 9666014
[TBL] [Abstract][Full Text] [Related]
10. Loss of disease tolerance during Citrobacter rodentium infection is associated with impaired epithelial differentiation and hyperactivation of T cell responses.
Kang E; Zhou G; Yousefi M; Cayrol R; Xia J; Gruenheid S
Sci Rep; 2018 Jan; 8(1):847. PubMed ID: 29339782
[TBL] [Abstract][Full Text] [Related]
11. CD4+-T-cell effector functions and costimulatory requirements essential for surviving mucosal infection with Citrobacter rodentium.
Bry L; Brigl M; Brenner MB
Infect Immun; 2006 Jan; 74(1):673-81. PubMed ID: 16369024
[TBL] [Abstract][Full Text] [Related]
12. CD3⁻NK1.1⁺ cells aid in the early induction of a Th1 response to an attaching and effacing enteric pathogen.
Reid-Yu SA; Small CL; Coombes BK
Eur J Immunol; 2013 Oct; 43(10):2638-49. PubMed ID: 23775576
[TBL] [Abstract][Full Text] [Related]
13. Vasoactive intestinal peptide ameliorates intestinal barrier disruption associated with Citrobacter rodentium-induced colitis.
Conlin VS; Wu X; Nguyen C; Dai C; Vallance BA; Buchan AM; Boyer L; Jacobson K
Am J Physiol Gastrointest Liver Physiol; 2009 Oct; 297(4):G735-50. PubMed ID: 19661153
[TBL] [Abstract][Full Text] [Related]
14. Saccharomyces boulardii ameliorates Citrobacter rodentium-induced colitis through actions on bacterial virulence factors.
Wu X; Vallance BA; Boyer L; Bergstrom KS; Walker J; Madsen K; O'Kusky JR; Buchan AM; Jacobson K
Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G295-306. PubMed ID: 18032474
[TBL] [Abstract][Full Text] [Related]
15. Citrobacter rodentium Infection Model for the Analysis of Bacterial Pathogenesis and Mucosal Immunology.
Kennedy CL; Hartland EL
Methods Mol Biol; 2018; 1725():77-89. PubMed ID: 29322410
[TBL] [Abstract][Full Text] [Related]
16. Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria.
Png CW; Lindén SK; Gilshenan KS; Zoetendal EG; McSweeney CS; Sly LI; McGuckin MA; Florin TH
Am J Gastroenterol; 2010 Nov; 105(11):2420-8. PubMed ID: 20648002
[TBL] [Abstract][Full Text] [Related]
17. Comparison of an espB gene fecal polymerase chain reaction assay with bacteriologic isolation for detection of Citrobacter rodentium infection in mice.
McKeel R; Douris N; Foley PL; Feldman SH
Comp Med; 2002 Oct; 52(5):439-44. PubMed ID: 12405637
[TBL] [Abstract][Full Text] [Related]
18. Citrobacter rodentium infection causes iNOS-independent intestinal epithelial dysfunction in mice.
Skinn AC; Vergnolle N; Zamuner SR; Wallace JL; Cellars L; MacNaughton WK; Sherman PM
Can J Physiol Pharmacol; 2006 Dec; 84(12):1301-12. PubMed ID: 17487239
[TBL] [Abstract][Full Text] [Related]
19. Colonic levels of vasoactive intestinal peptide decrease during infection and exogenous VIP protects epithelial mitochondria against the negative effects of IFNγ and TNFα induced during Citrobacter rodentium infection.
Maiti AK; Sharba S; Navabi N; Lindén SK
PLoS One; 2018; 13(9):e0204567. PubMed ID: 30252907
[TBL] [Abstract][Full Text] [Related]
20. MyD88 signaling in dendritic cells and the intestinal epithelium controls immunity against intestinal infection with C. rodentium.
Friedrich C; Mamareli P; Thiemann S; Kruse F; Wang Z; Holzmann B; Strowig T; Sparwasser T; Lochner M
PLoS Pathog; 2017 May; 13(5):e1006357. PubMed ID: 28520792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
